Maxigen Biotech Stock Last Dividend Paid
| 1783 Stock | TWD 43.70 0.50 1.13% |
Maxigen Biotech fundamentals help investors to digest information that contributes to Maxigen Biotech's financial success or failures. It also enables traders to predict the movement of Maxigen Stock. The fundamental analysis module provides a way to measure Maxigen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Maxigen Biotech stock.
Maxigen |
Maxigen Biotech Company Last Dividend Paid Analysis
Maxigen Biotech's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Maxigen Biotech has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers - Major (which currently averages 0.0) industry. This indicator is about the same for all Taiwan stocks average (which is currently at 0.0).
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Maxigen Fundamentals
| Return On Equity | 0.0926 | |||
| Return On Asset | 0.0454 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 84.7 M | |||
| Shares Owned By Insiders | 51.89 % | |||
| Shares Owned By Institutions | 2.28 % | |||
| Price To Earning | 33.55 X | |||
| Price To Book | 3.24 X | |||
| Price To Sales | 6.63 X | |||
| Revenue | 511.98 M | |||
| Gross Profit | 261.03 M | |||
| EBITDA | 130.56 M | |||
| Net Income | 87.67 M | |||
| Cash And Equivalents | 390.34 M | |||
| Cash Per Share | 5.62 X | |||
| Total Debt | 16.62 M | |||
| Debt To Equity | 1.50 % | |||
| Current Ratio | 7.81 X | |||
| Book Value Per Share | 14.75 X | |||
| Cash Flow From Operations | 117.59 M | |||
| Earnings Per Share | 1.23 X | |||
| Number Of Employees | 20 | |||
| Beta | 1.05 | |||
| Market Capitalization | 5.02 B | |||
| Total Asset | 1.27 B | |||
| Retained Earnings | (14 M) | |||
| Working Capital | 560 M | |||
| Current Asset | 623 M | |||
| Current Liabilities | 63 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.27 B |
About Maxigen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maxigen Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maxigen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maxigen Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.